226 related articles for article (PubMed ID: 9973200)
1. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
Noh SJ; Li Y; Xiong Y; Guan KL
Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
Fåhraeus R; Laín S; Ball KL; Lane DP
Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A.
Li J; Byeon IJ; Ericson K; Poi MJ; O'Maille P; Selby T; Tsai MD
Biochemistry; 1999 Mar; 38(10):2930-40. PubMed ID: 10074345
[TBL] [Abstract][Full Text] [Related]
4. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells.
Shimizu T; Awai N; Takeda K
Oncogene; 2000 Sep; 19(40):4640-6. PubMed ID: 11030153
[TBL] [Abstract][Full Text] [Related]
5. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor INK4: quantitative structure-function analyses of p18INK4C as an inhibitor of cyclin-dependent kinase 4.
Li J; Poi MJ; Qin D; Selby TL; Byeon IJ; Tsai MD
Biochemistry; 2000 Feb; 39(4):649-57. PubMed ID: 10651629
[TBL] [Abstract][Full Text] [Related]
7. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.
Timmermann S; Hinds PW; Münger K
Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
Zariwala M; Liu E; Xiong Y
Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
Easton J; Wei T; Lahti JM; Kidd VJ
Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
[TBL] [Abstract][Full Text] [Related]
11. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ
Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547
[TBL] [Abstract][Full Text] [Related]
12. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.
Franklin DS; Xiong Y
Mol Biol Cell; 1996 Oct; 7(10):1587-99. PubMed ID: 8898364
[TBL] [Abstract][Full Text] [Related]
13. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
[TBL] [Abstract][Full Text] [Related]
14. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
15. A p18 mutant defective in CDK6 binding in human breast cancer cells.
Lapointe J; Lachance Y; Labrie Y; Labrie C
Cancer Res; 1996 Oct; 56(20):4586-9. PubMed ID: 8840966
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
Jeffrey PD; Tong L; Pavletich NP
Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
[TBL] [Abstract][Full Text] [Related]
17. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
Suzuki T; Narita T; Uchida-Toita M; Yoshida M
Virology; 1999 Jul; 259(2):384-91. PubMed ID: 10388662
[TBL] [Abstract][Full Text] [Related]
19. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J
FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227
[TBL] [Abstract][Full Text] [Related]
20. Mutations associated with familial melanoma impair p16INK4 function.
Ranade K; Hussussian CJ; Sikorski RS; Varmus HE; Goldstein AM; Tucker MA; Serrano M; Hannon GJ; Beach D; Dracopoli NC
Nat Genet; 1995 May; 10(1):114-6. PubMed ID: 7647780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]